SHILPAMED.NSSHILPAMED.NSNSE

Revenue (LTM)

$12.9B

+11.6% YoY

Net Income (LTM)

$783M

+145.6% YoY

Free Cash Flow

$-1.1B

Revenue CAGR (5Y)

+7.4%

Marginsdeclining

FCF($1.1B)

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	9,002	11,400↑26.6%	10,434↓8.5%	11,531↑10.5%	12,864↑11.6%
Gross Profit	6,294	7,560↑20.1%	1,344↓82.2%	7,096↑428.1%	8,760↑23.5%
Operating Income	1,193	1,258↑5.5%	-97↓107.7%	3,762↑3996.3%	2,041↓45.8%
Net Income	1,478	607↓59.0%	-325↓153.6%	319↑198.0%	783↑145.6%
EBITDA	2,726	2,230↓18.2%	1,135↓49.1%	2,459↑116.7%	3,109↑26.4%
EPS Diluted	9.06	3.63↓60.0%	-1.88↓151.7%	1.83↑197.9%	4.02↑119.1%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	1,228	338↓72.5%	213↓37.0%	302↑41.8%	260↓14.1%
Total Current Assets	9,028	8,872↓1.7%	7,696↓13.3%	8,768↑13.9%	9,857↑12.4%
Total Assets	26,324	28,755↑9.2%	29,039↑1.0%	30,932↑6.5%	33,107↑7.0%
Total Current Liabilities	6,035	6,115↑1.3%	7,844↑28.3%	6,933↓11.6%	6,742↓2.8%
Total Liabilities	11,649	10,644↓8.6%	11,296↑6.1%	12,932↑14.5%	9,470↓26.8%
Total Equity	14,787	18,222↑23.2%	17,833↓2.1%	18,087↑1.4%	23,722↑31.2%
Total Debt	8,459	6,833↓19.2%	7,979↑16.8%	9,374↑17.5%	5,877↓37.3%
Net Debt	7,231	6,495↓10.2%	7,766↑19.6%	9,072↑16.8%	5,618↓38.1%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	469	1,051↑124.0%	1,799↑71.1%	1,367↓24.0%	1,322↓3.3%
Capital Expenditure	-3,542	-3,318↑6.3%	-2,267↑31.7%	-1,846↑18.6%	-2,436↓32.0%
Free Cash Flow	-3,073	-2,267↑26.2%	-467↑79.4%	-492↓5.3%	-1,115↓126.4%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	790	-975↓223.4%	-66↑93.3%	127↑293.6%	-32↓125.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance